Skip to content
10-Q

Quarterly Report

TENAYA THERAPEUTICS, INC. TNYA

0001193125-26-209084

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 217M sh
Shares Diluted Q1 2026 · Mar 31, 2026 216.88M sh
Shares Diluted Q1 2026 · Mar 31, 2025 109.87M sh
Capex Q1 2026 · Mar 31, 2026 $11K
Capex Q1 2026 · Mar 31, 2025 $383K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$19.23M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$23.11M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $80.89M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $100.55M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $53.77M
Stockholders Equity Q1 2026 · Mar 31, 2026 $106.19M
Stockholders Equity Q1 2026 · Dec 31, 2025 $123.27M
Stockholders Equity Q1 2026 · Mar 31, 2025 $119.4M
Stockholders Equity Q1 2026 · Dec 31, 2024 $92.85M
Current Liabilities Q1 2026 · Mar 31, 2026 $16.78M
Current Liabilities Q1 2026 · Dec 31, 2025 $15.44M
Total Liabilities Q1 2026 · Mar 31, 2026 $28.88M
Total Liabilities Q1 2026 · Dec 31, 2025 $23.66M
Current Assets Q1 2026 · Mar 31, 2026 $96.56M
Current Assets Q1 2026 · Dec 31, 2025 $105.59M
Total Assets Q1 2026 · Mar 31, 2026 $135.07M
Total Assets Q1 2026 · Dec 31, 2025 $146.92M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.09
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.24
Eps Basic Q1 2026 · Mar 31, 2026 −$0.09
Eps Basic Q1 2026 · Mar 31, 2025 −$0.24
Sga Expense Q1 2026 · Mar 31, 2026 $5.45M
Sga Expense Q1 2026 · Mar 31, 2025 $6.46M
Rd Expense Q1 2026 · Mar 31, 2026 $14.84M
Rd Expense Q1 2026 · Mar 31, 2025 $21.08M
Net Income Q1 2026 · Mar 31, 2026 −$19.27M
Net Income Q1 2026 · Mar 31, 2025 −$26.86M
Operating Income Q1 2026 · Mar 31, 2026 −$20.07M
Operating Income Q1 2026 · Mar 31, 2025 −$27.54M
Revenue Q1 2026 · Mar 31, 2026 $225K
Revenue Q1 2026 · Mar 31, 2025 $0